Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (11874)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Apr 14, 2015 (publication date) through Apr 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Su SB, Qin SY, Chen W, Luo W, Jiang HX. Carbohydrate antigen 19-9 for differential diagnosis of pancreatic carcinoma and chronic pancreatitis. World J Gastroenterol 2015; 21(14): 4323-4333 [PMID: 25892884 DOI: 10.3748/wjg.v21.i14.4323] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i14/4323.htm |
| Number | Citing Articles |
| 1 |
Sujani M. K. Gamage, Chamath D. Ranaweera, Tracie T. Cheng, Sharmin Aktar, Vinod Gopalan, Farhadul Islam. Current Cancer Biomarkers. 2023; : 11 doi: 10.2174/9789815079364123010005
|
| 2 |
Sunil Badami, Htay Htay Kyi, Sunil Upadhaya, Samer Al Hadidi. Pancreatic Adenocarcinoma Masquerading as Idiopathic Chronic Pancreatitis with Delayed Diagnosis. Case Reports in Oncology 2017; 10(3): 819 doi: 10.1159/000480076
|
| 3 |
Zhe-Ying Wang, Xiao-Qing Ding, Hui Zhu, Rui-Xian Wang, Xiao-Rong Pan, Jian-Hua Tong. KRAS Mutant Allele Fraction in Circulating Cell-Free DNA Correlates With Clinical Stage in Pancreatic Cancer Patients. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.01295
|
| 4 |
Shuichi MITSUNAGA, Motohiro KOJIMA, Masafumi IKEDA, Atsushi OCHIAI. Serum microRNAs as tumor markers for diagnosis of pancreatic cancer. Suizo 2017; 32(1): 56 doi: 10.2958/suizo.32.56
|
| 5 |
Masaki Kuwatani, Hiroshi Kawakami, Yoshimasa Kubota, Kazumichi Kawakubo, Yoichi M. Ito, Shinji Togo, Takaaki Ikeda, Ken Kusama, Yuka Kobayashi, Teizo Murata, Naoya Sakamoto. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosis. Pancreatology 2019; 19(4): 569 doi: 10.1016/j.pan.2019.04.007
|
| 6 |
Yuhao Zhao, Mao Yang, Shijia Wang, Sk Jahir Abbas, Junzhe Zhang, Yongsheng Li, Rong Shao, Yingbin Liu. An Overview of Epigenetic Methylation in Pancreatic Cancer Progression. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.854773
|
| 7 |
Jingjing Liu, Lei Hu, Bi Zhou, Chungen Wu, Yingsheng Cheng. Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis. Translational Oncology 2022; 18: 101357 doi: 10.1016/j.tranon.2022.101357
|
| 8 |
Min Seong Kim, Tae Joo Jeon, Ji Young Park, Jeongmin Choi, Won Chang Shin, Seong Eun Park, Ji-Young Seo, Young Moon Kim. Clinical Interpretation of Elevated CA 19-9 Levels in Obstructive Jaundice Following Benign and Malignant Pancreatobiliary Disease. The Korean Journal of Gastroenterology 2017; 70(2): 96 doi: 10.4166/kjg.2017.70.2.96
|
| 9 |
Andrii Khomiak, Marius Brunner, Maximilian Kordes, Stina Lindblad, Rainer Christoph Miksch, Daniel Öhlund, Ivonne Regel. Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer. Cancers 2020; 12(11): 3234 doi: 10.3390/cancers12113234
|
| 10 |
Ishtiaq Hussain, Mamoon Ur Rashid, Jamaluddin Saeed, Zarghoona Wajid, Deepika Sarvepalli, Effa Zahid, Sundas Jehanzeb, Sarfraz Ahmad. Novel therapeutic approaches for gastrointestinal malignancies. Diagnostics and Therapeutic Advances in GI Malignancies 2020; : 239 doi: 10.1007/978-981-15-5471-1_14
|
| 11 |
Yang Cheng, Kunyuan Wang, Lanlan Geng, Jingjing Sun, Wanfu Xu, Dingli Liu, Sitang Gong, Yun Zhu. Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma. EBioMedicine 2019; 40: 382 doi: 10.1016/j.ebiom.2019.01.003
|
| 12 |
Anelis Maria Marin, Michel Batista, Alexandre Luiz Korte de Azevedo, Talita Helen Bombardelli Gomig, Rodrigo Soares Caldeira Brant, Roger Chammas, Miyuki Uno, Diogo Dias Araújo, Dalila Luciola Zanette, Mateus Nóbrega Aoki. Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer. International Journal of Molecular Sciences 2023; 24(16): 12604 doi: 10.3390/ijms241612604
|
| 13 |
K. Passek, M. H. Bendels, D. Ohlendorf, E. Wanke, G. M. Oremek, D. A. Groneberg. Der Tumormarker CA 19-9. Zentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie 2017; 67(6): 327 doi: 10.1007/s40664-017-0211-3
|
| 14 |
Ding-Li Xu, Yi-Qun Wu, Chang Xin, Qi-Feng Zhou, Ming-Liang Chen, Huan-Jun Yan. Simple cholangitis induces extremely and recurrently elevated serum carbohydrate antigen 19-9 level. Hepatobiliary & Pancreatic Diseases International 2019; 18(3): 294 doi: 10.1016/j.hbpd.2019.03.008
|
| 15 |
Hunter B. Moore, Rachel Culp-Hill, Julia A. Reisz, Peter J. Lawson, Angela Sauaia, Richard D. Schulick, Marco Del Chiaro, Trevor L. Nydam, Ernest E. Moore, Kirk C. Hansen, Angelo D'Alessandro. The metabolic time line of pancreatic cancer: Opportunities to improve early detection of adenocarcinoma. The American Journal of Surgery 2019; 218(6): 1206 doi: 10.1016/j.amjsurg.2019.08.015
|
| 16 |
Jie Xia, Huarong Zhang, Qingzhou Guan, Shanshan Wang, Yawei Li, Jiajing Xie, Meifeng Li, Haiyan Huang, Haidan Yan, Ting Chen. Qualitative diagnostic signature for pancreatic ductal adenocarcinoma based on the within‐sample relative expression orderings. Journal of Gastroenterology and Hepatology 2021; 36(6): 1714 doi: 10.1111/jgh.15326
|
| 17 |
Weiwei Li, Jianli Wang, Yanhua Li, Qiuju Yue, Miaohang Cui, Jinlong Liu. KRAS Mutations in Peripheral Blood (with or without CA19-9) for Differential Diagnosis of Pancreatic Cancer and Chronic Pancreatitis: a Systematic Review and Meta-analysis. Indian Journal of Surgery 2022; 84(4): 615 doi: 10.1007/s12262-022-03475-4
|
| 18 |
Wei Wang, Li Chai, Naiyi Zhu, Qingrou Wang, Yiran Zhou, Weimin Chai. Clinical significance of pancreatic calcifications: a 15-year single-center observational study. European Journal of Medical Research 2022; 27(1) doi: 10.1186/s40001-022-00725-9
|
| 19 |
Xuan Zhang, Zhiming Zeng, Huiyi Liu, Li Xu, Xin Sun, Jing Xu, Guosheng Song. Recent development of a magneto-optical nanoplatform for multimodality imaging of pancreatic ductal adenocarcinoma. Nanoscale 2022; 14(9): 3306 doi: 10.1039/D1NR08394E
|
| 20 |
Junhao Xie, Xianzhu Zhou, Rui Wang, Jiulong Zhao, Jian Tang, Qichen Zhang, Yiqi Du, Yanan Pang. Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma. Medicine 2021; 100(23): e26135 doi: 10.1097/MD.0000000000026135
|
| 21 |
Jean-Marc Dumonceau, Myriam Delhaye, Nicolas Charette, Annarita Farina. Challenging biliary strictures: pathophysiological features, differential diagnosis, diagnostic algorithms, and new clinically relevant biomarkers - part 1. Therapeutic Advances in Gastroenterology 2020; 13: 175628482092729 doi: 10.1177/1756284820927292
|
| 22 |
Haibo Xing, Jing Wang, Yanling Wang, Mengting Tong, Hong Hu, Changxin Huang, Da Li. Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis. Gastroenterology Research and Practice 2018; 2018: 1 doi: 10.1155/2018/8704751
|
| 23 |
Jisce R Puik, Laura L Meijer, Tessa YS Le Large, Mireia Mato Prado, Adam E Frampton, Geert Kazemier, Elisa Giovannetti. miRNA profiling for diagnosis, prognosis and stratification of cancer treatment in cholangiocarcinoma. Pharmacogenomics 2017; 18(14): 1343 doi: 10.2217/pgs-2017-0010
|
| 24 |
Kai Jia, Xia Zhao, Xueyi Dang. Mass spectrometry‑based iTRAQ analysis of serum markers in patients with pancreatic cancer. Oncology Letters 2020; doi: 10.3892/ol.2020.11491
|
| 25 |
Bishnupriya Chhatriya, Moumita Mukherjee, Sukanta Ray, Barsha Saha, Somdatta Lahiri, Sandip Halder, Indranil Ghosh, Sujan Khamrui, Kshaunish Das, Samsiddhi Bhattacharjee, Saroj Kant Mohapatra, Srikanta Goswami. Transcriptome analysis identifies putative multi-gene signature distinguishing benign and malignant pancreatic head mass. Journal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02597-1
|
| 26 |
E. A. Dubtsova, L. V. Vinokurova, K. A. Nikolskaya, M. A. Kiryukova, D. S. Bordin. Chronic pancreatitis as a risk factor for pancreatic cancer (a clinical case). Almanac of Clinical Medicine 2018; 46(5): 542 doi: 10.18786/2072-0505-2018-46-5-542-549
|
| 27 |
Lakshmi Sai Niharika Janga, Hembashima G Sambe, Mohamed Yasir, Ruzhual K Man, Amaresh Gogikar, Ankita Nanda, Lubna Mohammed. Holistic Understanding of the Role of Carbohydrate Antigen 19-9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review. Cureus 2023; doi: 10.7759/cureus.44382
|
| 28 |
Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, Chun-Chieh Yeh, Chao-Ming Tseng, Wen-Hsin Huang, Teng-Yu Lee, Chia-Shen Chu, Jaw-Town Lin. Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma. Journal of the Formosan Medical Association 2022; 121(12): 2601 doi: 10.1016/j.jfma.2022.07.003
|
| 29 |
Bin Huang, Chang Xin, Huanjun Yan, Zhewei Yu.
A Machine Learning Method for a Blood Diagnostic Model of Pancreatic Cancer Based on microRNA Signatures
. Critical Reviews in Immunology 2024; 44(3): 13 doi: 10.1615/CritRevImmunol.2023051250
|
| 30 |
Ömer BİNİCİER, Zehra PAKÖZ. Carbohydrate antigen 19-9 levels in early acute pancreatitis. Akademik Gastroenteroloji Dergisi 2019; 19(1): 5 doi: 10.17941/agd.728662
|
| 31 |
Boqiang Zhao, Boyue Zhao, Fangyao Chen. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a systematic review and meta-analysis. European Journal of Gastroenterology & Hepatology 2022; 34(9): 891 doi: 10.1097/MEG.0000000000002415
|
| 32 |
Sven H Loosen, Ulf P Neumann, Christian Trautwein, Christoph Roderburg, Tom Luedde. Current and future biomarkers for pancreatic adenocarcinoma. Tumor Biology 2017; 39(6): 101042831769223 doi: 10.1177/1010428317692231
|
| 33 |
Huimin Zhang, Wei Han, Meng Jin, Yamin Lai, Xi Wang, Jian Wang, Yao Yao, Dong Wu, Jiaming Qian, Hong Yang. Establishment and Verification of a Scoring Model for the Differential Diagnosis of Pancreatic Cancer and Chronic Pancreatitis. Pancreas 2018; 47(4): 459 doi: 10.1097/MPA.0000000000001029
|
| 34 |
Ville J. Sallinen, Helka Parviainen. Textbook of Pancreatic Cancer. 2021; : 489 doi: 10.1007/978-3-030-53786-9_32
|
| 35 |
David Sefrioui, France Blanchard, Emmanuel Toure, Paul Basile, Ludivine Beaussire, Claire Dolfus, Anne Perdrix, Marianne Paresy, Michel Antonietti, Isabelle Iwanicki-Caron, Raied Alhameedi, Stephane Lecleire, Alice Gangloff, Lilian Schwarz, Florian Clatot, Jean-Jacques Tuech, Thierry Frébourg, Fabrice Jardin, Jean-Christophe Sabourin, Nasrin Sarafan-Vasseur, Pierre Michel, Frédéric Di Fiore. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours. British Journal of Cancer 2017; 117(7): 1017 doi: 10.1038/bjc.2017.250
|
| 36 |
O Joe Hines, Stephen J Pandol. Management of chronic pancreatitis. BMJ 2024; : e070920 doi: 10.1136/bmj-2023-070920
|
| 37 |
Qi Zhang, Mao Ye, Cheng Lin, Manyi Hu, Yangyang Wang, Yu Lou, Quanming Kong, Jungang Zhang, Junjian Li, Yuhua Zhang, Tianxing Yang, Xu Sun, Weiyun Yao, Yongfei Hua, Haifeng Huang, Minghui Xu, Xiaoguang Wang, Xin Yu, Weifeng Tao, Runtian Liu, Yuming Gao, Tian Wang, Jianing Wang, Xiaobao Wei, Jiangchao Wu, Zhengping Yu, Chengwu Zhang, Chaohui Yu, Xueli Bai, Tingbo Liang. Mass cytometry-based peripheral blood analysis as a novel tool for early detection of solid tumours: a multicentre study. Gut 2023; 72(5): 996 doi: 10.1136/gutjnl-2022-327496
|
| 38 |
Hongquan Qiu, Liang Zhang, Dongzhi Wang, Yu Zhang, Hongyu Cai, Haiyan Miao, Feihu Chu, Osamah Ibrahim Khalaf. ZNF488 Promotes the Invasion and Migration of Pancreatic Carcinoma Cells through the Akt/mTOR Pathway. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/4622877
|
| 39 |
G.G. Varvanina, K.A. Lesko, D.S. Bordin, E.A. Dubtsova, M.V. Malykh, K.K. Noskova, L.V. Vinokurova. Blood biomarkers and computed tomography for differential diagnosis of pancreatic cancer and chronic pancreatitis. Dokazatel'naya gastroenterologiya 2021; 10(4): 12 doi: 10.17116/dokgastro20211004112
|
| 40 |
Yang Yang, Guangbing Li, Yu Zhang, Yunfeng Cui, Jun Liu. Protein Induced by Vitamin K Absence II: A Potential Biomarker to Differentiate Pancreatic Ductal Adenocarcinoma from Pancreatic Benign Lesions and Predict Vascular Invasion. Journal of Clinical Medicine 2023; 12(8): 2769 doi: 10.3390/jcm12082769
|